Exportar Publicação

A publicação pode ser exportada nos seguintes formatos: referência da APA (American Psychological Association), referência do IEEE (Institute of Electrical and Electronics Engineers), BibTeX e RIS.

Exportar Referência (APA)
Bravo, A. M. & Crespo de Carvalho, J. (2012). A country perspective in exploring the links between hospital pharmacies and pharmaceutical industry: a case study application. Pharmaceutical Regulatory Affairs.
Exportar Referência (IEEE)
B. A. M. and J. L. Carvalho,  "A country perspective in exploring the links between hospital pharmacies and pharmaceutical industry: a case study application", in Pharmaceutical Regulatory Affairs, 2012
Exportar BibTeX
@article{m.2012_1714318494074,
	author = "Bravo, A. M. and Crespo de Carvalho, J.",
	title = "A country perspective in exploring the links between hospital pharmacies and pharmaceutical industry: a case study application",
	journal = "Pharmaceutical Regulatory Affairs",
	year = "2012",
	volume = "",
	number = "",
	doi = "10.4172/2167-7689.S11-001",
	url = "https://www.omicsgroup.org/journals/pharmaceutical-regulatory-affairs-open-access.php"
}
Exportar RIS
TY  - JOUR
TI  - A country perspective in exploring the links between hospital pharmacies and pharmaceutical industry: a case study application
T2  - Pharmaceutical Regulatory Affairs
AU  - Bravo, A. M.
AU  - Crespo de Carvalho, J.
PY  - 2012
SN  - 2167-7689
DO  - 10.4172/2167-7689.S11-001
UR  - https://www.omicsgroup.org/journals/pharmaceutical-regulatory-affairs-open-access.php
AB  - The pharmaceutical industry is one of the firms where the search for quality is very close to compliance. Yet a major paradigm change is occurring in this industry due to the increase of returns and recalls. Hence, in this paper the authors combine the findings of previous literature reviews with a case study approach. Findings from previous literature reviews emerged from the links explored between pharmaceutical drugs quality, reverse logistics and sustainability. With the addition of a case study on a global manufacturing corporation in the area of generic drugs products one step further is introduced: understanding the type of returns companies receive, in particular from hospital pharmacies. With this approach authors are creating a link between two different parties: the application of a quality by design (QbD) risk management approach with the reduction of variability and risk of noncompliance, through the increase of knowledge and value into their products and processes.
ER  -